MedPath

Effects of timing of food intake on glucose metabolism and the brain during a hypocaloric diet in obese subjects

Recruiting
Conditions
obesity, type 2 diabetes
Registration Number
NL-OMON22981
Lead Sponsor
AMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

men

>50 y

Exclusion Criteria

Use of any medication except for those related to treatment of components of the metabolic syndrome (excluding insulin, oral glucose lowering drugs, beta-blockers)

Any actual medical condition except for treated hypothyroidism and the metabolic syndrome

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Insulin sensitivity (hyperinsulinemic euglycemic clamp)<br /><br>2. Diencephalic SERT ( [123I]FP-CIT SPECT) <br /><br>3. Brain 5-HT neurotransmission (pharmacological MRI (phMRI) using citalopram). <br>
Secondary Outcome Measures
NameTimeMethod
Motivation and impulse control<br /><br>Abdominal and liver fat<br /><br>Circulating hormones and substrates: blood drawing<br /><br>Sleep duration<br /><br>Resting energy expenditure<br /><br>Sympathetic and parasympathetic activity<br /><br>Feeding behaviour<br>
© Copyright 2025. All Rights Reserved by MedPath